IDS spends £15.5m on another buyout

  • IDS

MEDICAL testing kit manufacturer IDS has made another multi-million pound acquisition which will transform the size of the business.

Drugs group gets tonic from broker

THE FTSE 100 opened relatively flat, but slipped into negative territory, dipping below the 6700 mark at lunchtime, led downwards mainly by the mining sector.

Medical kit firm doubles earnings

  • IDS

MEDICAL testing kit company IDS said yesterday it had doubled earnings as it prepares to relocate a manufacturing facility from Denmark to the North-East.

IDS shares once again in demand

  • IDS

SHARES in Angel Biotechnology surged in value by 44% after the company announced that it has signed a contract with Materia Medica, a Russian based group.

Medical test kit firm goes for dominance

  • IDS

MEDICAL testing kit company IDS is making its biggest acquisition – a Danish company for £17m.

ICI price soars after takeover rebuff

  • IDS

Uk equities traded within a tight range yesterday, closing 28.90 points lower at 6703.50, despite the prospect of further takeover activity.

Toon and country

At last! I have a VIP (Very Important Penpal) in my email address book.

Th_nk of number, double it

Crowned the 2006 Culture and Creative category winner, TH_NK is a business that has undergone substantial growth in the competitive world of new media.

As rate rises, so do 4%-plus pay deals

  • IDS

The number of UK pay deals above 4% is picking up as the level of inflation rises, says a new report from Income Data Services (IDS).


  • IDS

Postal workers are being balloted on strike action; pay deals are averageing 3.5%; and there is a question over the Boots takeover.

More for some

  • IDS

Average pay deals remained at 3.5% in recent months, although one in three settlements is now worth at least 4%, new figures showed today.

Life begins at 40 with North stocks

It pays to keep an eye on the shares of North-East companies, discovers Vinay Bedi, divisional director of Newcastle-based investment management firm Wise Speke in his regular half-yearly review of the North 40 stocks.

IDS detects the winning formula

  • IDS

A poineering North-East company working at the cutting edge of medical research has landed another major award.

Global growth pushes profits

  • IDS

Fast-growing biotech company IDS is expected to see profits rise by 74% this year as the business expands around the globe and becomes more efficient.

Barratt sees share price slip lower

  • IDS

Aim listed Biofuels Corporation warned yesterday that full year earnings will be lower than market expectations.

Arriva profits rise despite fuel bill

The transport group Arriva yesterday reported a 6.4% increase in pre-tax profits to £109.8m; this increase came about despite an extra £20m fuel bill for the year.

New director

  • IDS

A producer of diagnostic test kits for the biotechnology industry has appointed a new technical director.

Celebrating achievement

  • BBC

Achievement in the business world was celebrated in some spectacular events during 2006.

Steve is Tees Valley's best

The business executive declared the best in the Tees Valley has praised his staff for the part they have played in the company's success.

IDS expands with move into Austrian market

  • IDS

Ambitious Immunodiagnostic Systems Holdings (IDS) has moved into the Austrian market as its latest overseas territory.

Dynamic dozen vie for Journal awards

The shortlist of the best businesspeople in the region has been revealed.

FTSE continues upward trend

The FTSE 100 Index continued its climb northwards yesterday as world markets were left relatively unshaken following news that North Korea had carried out nuclear testing.

Private firms 4% pay rise

  • IDS

Pay rises in private firms will increase at twice the rate of those in the public sector in the coming year, a report predicted today.

Bosses 'worth' wages of 127 staff

  • IDS

The average pay of FTSE100 chief executives jumped 40% in the past year to nearly £3m, according to a report from the pay experts.

IDS trading update boost

  • IDS

There was little in the way of corporate newsflow to interest investors who follow the companies in the regional portfolio yesterday, with few announcements, leading to a fairly benign trading session.

X-ray group sees profitable future

  • IDS

In the regional portfolio, Bede announced its interim figures and as a whole they were well received by the market.

Profits soar as IDS looks forward to more growth

  • IDS

Profits have more than quadrupled to £1.17m at biotech business IDS in South Tyneside.

Good advice

  • IDS

So many businesses have an idea, project or problem on the shelf gathering dust; things you know would help your business move forward, but you haven't the time, knowledge or skills to do anything about.


David Whetstone
Culture Editor
Graeme Whitfield
Business Editor
Mark Douglas
Newcastle United Editor
Stuart Rayner
Sports Writer